We thank Dr Trevethan for his comment on our recently published paper. Consistent with our aims, the study determined that in a small sample, sourced from a Podiatry clinic and the local community, a toe brachial index (TBI) measured with an automated device has acceptable sensitivity and specificity for peripheral arterial disease (PAD) using color duplex ultrasound as the reference standard. In addition, the study showed that toe blood pressure (TBP) of 70 mmHg had perfect specificity for PAD (100%) but poor sensitivity (45.86%). Sensitivity and specificity of the TBI for PAD were calculated with two commonly reported thresholds (<0.70 and <0.75). To further investigate the use of these two thresholds, a receiver operating curve (ROC) analysis was conducted which suggested that the optimum threshold for a TBI was 0.72. From this we were able to suggest that, of the two regularly used thresholds for a TBI, the higher threshold of <0.75 is likely to include disease-free individuals. This was supported by lower specificity for a threshold of <0.75 than when a threshold of <0.70 was used. Therefore, rather than abandoning both thresholds as suggested by the author, we recommended the lower threshold of <0.70 may be clinically more effective for identifying those with disease based on the ROC analysis.
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In relation to TBP, there is little available evidence for thresholds that are indicative of non-symptomatic PAD in community-based samples. Most available literature investigates diseased populations and thresholds for healing or ischemic rest pain rather than diagnosis of PAD. [1] [2] [3] [4] Due to the inclusion of a sample less likely to have severe disease and, in the absence of a widely accepted threshold for diagnosing PAD by TBP, a higher threshold for impaired healing reported in the literature (<70 mmHg) 3 was used for calculation of sensitivity and specificity. The sample mean for TBP was 101 mmHg, and the mean TBI was 0.72. These were interpreted as non-pathological results suggesting that, in this sample, reducing the TBP threshold for non-healing to other published healing thresholds, e.g. <30 mmHg 3 and comparing them, as we had done for the TBI, was not appropriate as few participants have TBP below this level. We agree it is entirely possible that TBP >70 mmHg is likely to include people with PAD and that establishing appropriate thresholds for TBP for diagnosis of PAD is urgently required. In regard to our study, establishing a new threshold would require a significantly larger sample size than we recruited and, therefore, was not our aim for either the TBP, or the TBI. To further clarify, our comments in relation to the potential for limited utility of TBP for screening were in relation to the threshold we examined.
Generally, results of diagnostic accuracy studies of lower limb vascular assessment need to be interpreted with caution, particularly where angiography is used as the reference standard (indicating high rates of disease), or small samples or particular patient populations are involved. The results of these studies are invariably affected by limited generalisability and risk of spectrum bias. 5, 6 We agree that positive and negative predictive values are one aspect of diagnostic accuracy, providing an estimate of the likelihood of presence or absence of disease based on a positive or negative test result. However, we are of the opinion that such an evaluation needs to be undertaken in a much larger communitybased population which accurately reflects disease prevalence characteristics and where appropriately powered sub-analyses can be conducted to ensure these predictive values are of clinical relevance.
